Iron deficiency anemia (IDA) remains a significant global public health concern, affecting populations across both developing and developed nations. The World Health Organization (WHO) estimates that in 2019, approximately 1.62 billion people were affected by anemia, with iron deficiency being the most common cause. This condition disproportionately impacts vulnerable groups, including women, children, and populations in low- and middle-income countries. In the United States, the Centers for Disease Control and Prevention (CDC) reports a substantial prevalence of IDA, particularly among certain demographic groups, including pregnant women and young children (CDC, 2020). The impact of IDA is particularly evident in regions like India, where the Indian Council of Medical Research (ICMR) highlights concerning trends and the need for targeted interventions to address iron deficiency, particularly among women and children. Studies suggest that improved iron status in populations is essential for reducing the prevalence of IDA and its associated complications, such as cognitive impairment, fatigue, and weakened immune function. Recent advances in diagnostics, including point-of-care testing, have improved the identification and management of anemia in primary healthcare settings. Addressing IDA involves comprehensive strategies such as iron supplementation, dietary improvements, and public health initiatives like the Weekly Iron and Folic Acid Supplementation Program in India. The global efforts to combat nutritional anemia underscore the importance of multifaceted approaches to prevention and control. Ultimately, tackling IDA in India will require a multi-sectoral approach, with collaboration between government agencies, healthcare providers, research institutions, and local communities to ensure the widespread success of interventions in reducing iron deficiency and improving overall health outcomes.
Read full abstract